CAMBRIDGE, Mass., May 15 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. announced today that Idenix management will present a corporate overview at the upcoming Citi 2007 Healthcare Conference on Tuesday, May 22nd at 3:30 p.m. (EDT) in New York City.
The live and archived webcast of the presentation can be accessed under “Calendar of Events” in the Idenix Investor Center at www.idenix.com. Please log in approximately 5-10 minutes before the event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conference. The company presentation will be available for download in PDF format in the “Investor Presentations” section of the Investor Center immediately following the presentation.
About Idenix
Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of human viral and other infectious diseases. Idenix’s current focus is on the treatment of infections caused by hepatitis B virus, hepatitis C virus and human immunodeficiency virus (HIV). For further information about Idenix, please refer to www.idenix.com.
Idenix Pharmaceuticals’ Contacts:
Media: Teri Dahlman (617) 995-9905
Investors: Amy Sullivan (617) 995-9838
Idenix Pharmaceuticals
CONTACT: Media, Teri Dahlman +1-617-995-9905, or Investors, Amy Sullivan,+1-617-995-9838, both of Idenix Pharmaceuticals
Web site: http://www.idenix.com//
